This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Clarivate PLC (CLVT) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Clarivate PLC (CLVT) delivered earnings and revenue surprises of 29.41% and 3.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Docebo Inc. (DCBO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Docebo Inc. (DCBO) closed the most recent trading day at $35.01, moving +0.89% from the previous trading session.
Docebo Inc. (DCBO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Docebo Inc. (DCBO) closed at $36.70, marking a +1.02% move from the previous day.
Docebo Inc. (DCBO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Docebo Inc. (DCBO) closed the most recent trading day at $37.44, moving +0.08% from the previous trading session.
Docebo Inc. (DCBO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Docebo Inc. (DCBO) closed at $39.50, marking a -1.94% move from the previous day.
Docebo Inc. (DCBO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Docebo Inc. (DCBO) closed at $37.36, marking a +1.58% move from the previous day.
Docebo Inc. (DCBO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Docebo Inc. (DCBO) closed at $35.83, marking a +0.73% move from the previous day.
Docebo Inc. (DCBO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Docebo Inc. (DCBO) closed the most recent trading day at $35.21, moving -0.28% from the previous trading session.
New Strong Buy Stocks for December 29th
by Zacks Equity Research
SPNS, CRS, DHT, DCBO and ENTX have been added to the Zacks Rank #1 (Strong Buy) List on December 29, 2022.
Does Docebo Inc. (DCBO) Have the Potential to Rally 81% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at an 80.8% upside potential for Docebo Inc. (DCBO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
New Strong Buy Stocks for November 22nd
by Zacks Equity Research
DCBO, APPF, AMEH, FUTU and ZEUS have been added to the Zacks Rank #1 (Strong Buy) List on November 22, 2022.
Docebo Inc. (DCBO) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Docebo Inc. (DCBO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Predict an 114% Upside in Docebo Inc. (DCBO): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Docebo Inc. (DCBO) points to an 113.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Docebo Inc. (DCBO) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Docebo Inc. (DCBO) delivered earnings and revenue surprises of 300% and 2.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ON24 (ONTF) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
ON24 (ONTF) delivered earnings and revenue surprises of 56.25% and 0.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
KORE Group Holdings, Inc. (KORE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
KORE Group Holdings, Inc. (KORE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Docebo Inc. (DCBO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Docebo Inc. (DCBO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Docebo Inc. (DCBO) Climb 131% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 131.2% in Docebo Inc. (DCBO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Docebo Inc. (DCBO) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Docebo Inc. (DCBO) delivered earnings and revenue surprises of 0% and 0.89%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Inseego (INSG) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Inseego (INSG) delivered earnings and revenue surprises of 18.18% and 1.12%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Docebo Inc. (DCBO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Docebo Inc. (DCBO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thermon Group (THR) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Thermon Group (THR) delivered earnings and revenue surprises of 177.78% and 26.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
DoubleVerify Holdings (DV) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
DoubleVerify (DV) delivered earnings and revenue surprises of 50% and 7.82%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Docebo Inc. (DCBO) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Docebo Inc. (DCBO) delivered earnings and revenue surprises of -425% and 0.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Docebo (DCBO) This Earnings Season?
by Zacks Equity Research
Docebo (DCBO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.